Blood test duo may spot sepsis danger early in seniors
NCT ID NCT07332715
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether combining two blood markers—uric acid/albumin ratio and lactate—can help predict which older adults (65+) with sepsis will develop kidney injury, need blood pressure support, or die within 28 days. Researchers will follow 80 ICU patients who do not have kidney damage at the start. The goal is to find an easy, low-cost way to identify high-risk patients early and guide treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istinye Üniversity
Istanbul, Merkez Mahallesi, 34250, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which emergency dialysis saves more lives? a new study investigates
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- A simple sensor on the back could warn of kidney danger during heart surgery
- Can tailored nutrition boost recovery in the ICU?